February 2025's Estimated Undervalued Stock Selections For Savvy Investors

As global markets navigate a landscape marked by volatile corporate earnings and geopolitical tensions, investors are keenly observing the impact of AI competition and central bank policies on stock performance. Amidst this uncertainty, identifying undervalued stocks can be a strategic move, as these equities may offer potential value relative to their current market price when considering factors such as solid fundamentals or promising growth prospects.

Top 10 Undervalued Stocks Based On Cash Flows

Name	Current Price	Fair Value (Est)	Discount (Est)
Reach Subsea (OB:REACH)	NOK8.06	NOK16.12	50%
TF Bank (OM:TFBANK)	SEK376.00	SEK750.28	49.9%
Telefonaktiebolaget LM Ericsson (OM:ERIC B)	SEK82.94	SEK165.72	50%
Tongqinglou Catering (SHSE:605108)	CN¥20.86	CN¥41.56	49.8%
Decisive Dividend (TSXV:DE)	CA$5.97	CA$11.89	49.8%
Northwest Bancshares (NasdaqGS:NWBI)	US$13.23	US$26.31	49.7%
Groupe Dynamite (TSX:GRGD)	CA$16.11	CA$32.07	49.8%
Sociedad Química y Minera de Chile (NYSE:SQM)	US$37.70	US$75.20	49.9%
Verra Mobility (NasdaqCM:VRRM)	US$26.04	US$51.68	49.6%
Kyndryl Holdings (NYSE:KD)	US$43.45	US$86.66	49.9%

Click here to see the full list of 928 stocks from our Undervalued Stocks Based On Cash Flows screener.

Let's dive into some prime choices out of the screener.

ALTEOGEN (KOSDAQ:A196170)

Overview: ALTEOGEN Inc. is a biotechnology company specializing in the development of long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩20.04 trillion.

Operations: The company's revenue segment is focused on biotechnology, generating approximately ₩74.38 billion.

Estimated Discount To Fair Value: 48.5%

Alteogen Inc. is trading significantly below its estimated fair value, with a share price of ₩392,000 compared to a calculated fair value of ₩761,427.11. The company's revenue is projected to grow at 84.2% annually, outpacing the market average and contributing to expectations of profitability within three years. Recent strategic moves include a private placement raising KRW 154 billion and an exclusive licensing agreement with Daiichi Sankyo for ALT-B4 technology, potentially enhancing future cash flows through milestone payments and royalties.

• Our growth report here indicates ALTEOGEN may be poised for an improving outlook.
• Click here and access our complete balance sheet health report to understand the dynamics of ALTEOGEN.

Hua Hong Semiconductor (SEHK:1347)

Overview: Hua Hong Semiconductor Limited is an investment holding company that manufactures and sells semiconductor products, with a market capitalization of approximately HK$53.94 billion.

Operations: Hua Hong Semiconductor generates revenue primarily from the manufacturing and sale of semiconductor products.

Estimated Discount To Fair Value: 47.9%

Hua Hong Semiconductor is trading at HK$27.2, significantly below its estimated fair value of HK$52.24, suggesting it may be undervalued based on cash flows. Despite a decline in profit margins from 16.4% to 6.2%, earnings are projected to grow 27.3% annually, outpacing the Hong Kong market's average growth rate of 11.3%. Recent leadership changes with Mr. Peng Bai as president could influence strategic direction and operational efficiency moving forward.

• Our expertly prepared growth report on Hua Hong Semiconductor implies its future financial outlook may be stronger than recent results.
• Take a closer look at Hua Hong Semiconductor's balance sheet health here in our report.

Semiconductor Manufacturing International (SEHK:981)

Overview: Semiconductor Manufacturing International Corporation is an investment holding company involved in the manufacture, testing, and sale of integrated circuits across the United States, China, and Eurasia with a market cap of approximately HK$483.49 billion.

Operations: The company generates revenue of $7.50 billion from its integrated circuits manufacturing and sales operations across the United States, China, and Eurasia.

Estimated Discount To Fair Value: 49.4%

Semiconductor Manufacturing International is trading at HK$47.9, well below its estimated fair value of HK$94.73, highlighting potential undervaluation based on cash flows. Earnings are projected to grow significantly at 23.1% annually, surpassing the Hong Kong market's rate of 11.3%. However, profit margins have decreased from 17.8% to 7.5%, and recent impairment charges may affect financial stability despite anticipated revenue growth of around $8 billion for the year-end, exceeding industry averages.

• Our earnings growth report unveils the potential for significant increases in Semiconductor Manufacturing International's future results.
• Click here to discover the nuances of Semiconductor Manufacturing International with our detailed financial health report.

Make It Happen

• Gain an insight into the universe of 928 Undervalued Stocks Based On Cash Flows by clicking here.
• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
• Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com